Sideritis Supplementation and Performance
ConditionAthletic Performance
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorUniversity of Thessaly
About this trial
The purpose of this study is to examine the effect of sideritis consumption on physiological and performance indicators in adult subjects and compare it with the control trial.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy Individuals aged 18-40 years
Disqualifiers
Musculoskeletal Injury
Dietary supplements
Medication
Trial design
Design model
Crossover
Treatments tested in this trial
950 mg of Sideritis Scardica (SidTea+) extract one hour pre-exercise
Dietary supplement950 mg of Sideritis Scardica (SidTea+) extract one hour pre-exercise during exercise day
950 mg of placebo one hour pre-exercise
Dietary supplement950 mg of placebo one hour pre-exercise during exercise day
Treatment groups
12 Participants
are divided into 2 treatment groupsGroup A: Sideritis Scardica (SidTea+) extractExperimental treatment 1 intervention
Group B: Placebo SupplementationPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in Blood lactate
Blood lactate concentration will be estimated using an analyzer.
Time frame
Change from baseline to 15, 30, 45, 60 minutes during exercise and immediately post-exercise2
Change in mean respiratory quotient during exercise
The mean respiratory quotient during exercise will be measured using a gas analyzer
Time frame
Mean respiratory quotient will be measured during 60 minute of exercise3
Change in mean oxygen consumption during exercise
Mean oxygen consumption during exercise will be measured using a gas analyzer
Time frame
Mean oxygen consumption will be measured during 60 minute of exercise4
Change in mean Heart rate during exercise
Mean heart rate during exercise will be measured using a heart rate monitor
Time frame
Mean heart rate will be measured during 60 minute of exerciseSecondary outcomes
1
Body weight
Body weight will be estimated using beam balance scale
Time frame
Baseline2
Body fat (%)
Body fat will be measured by bioelectrical impedance analysis
Time frame
Baseline3
Resting Heart Rate
Resting heart rate will be measured using a heart rate sensor
Time frame
Baseline4
Diastolic and systolic blood pressure
Diastolic and systolic blood pressure will be measured using a manual sphygmomanometer
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: